| URL | https://www.globenewswire.com/news-release/2020/07 |
| Source | Globe Newswire |
| Date Published | 07/22/2020 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Altimmune, Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | Outsourced |
| City reshored to: | Rockville |
| State(s) reshored to: | MD |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | AdCOVID- single-dose intranasal vaccine candidate |
| What domestic positive factors made reshoring more attractive? | Under-utilized capacity, covid-19 |